Papillary serous cystadenocarcinoma
Papillary serous cystadenocarcinoma | |
---|---|
Medium power slide of ovarian serous adenocarcinoma stained using haematoxylin and eosin. | |
Classification and external resources | |
Specialty | oncology |
ICD-10 | C56 |
ICD-9-CM | 183.0 |
ICD-O | M8460/3 |
MeSH | D000231 |
Papillary serous cystadenocarcinomas are the most common form of malignant ovarian cancer making up 26 percent of ovarian tumours in women aged over 20 in the United States.[1]
As with most ovarian tumours, due to the lack of early signs of disease these tumours can be large when discovered and have often metastasized, often by spreading along the peritoneum.[3]
Histopathology
Papillary serous cystadenocarcinomas may exhibit psammoma bodies upon histopathology.[4]
Gallery
- Papillary serous cystadenoma
External links
References
- ↑ Kosary, Carol L. (2007). "Chapter 16: Cancers of the Ovary". In Ries, LAG; Young, JL; Keel, GE; Eisner, MP; Lin, YD; Horner, M-J. SEER Survival Monograph: Cancer Survival Among Adults: US SEER Program, 1988-2001, Patient and Tumor Characteristics. SEER Program. NIH Pub. No. 07-6215. Bethesda, MD: National Cancer Institute. pp. 133–144.
- ↑ Kosary, Carol L. (2007). "Chapter 16: Cancers of the Ovary" (PDF). In Baguio, RNL; Young, JL; Keel, GE; Eisner, MP; Lin, YD; Horner, M-J. SEER Survival Monograph: Cancer Survival Among Adults: US SEER Program, 1988-2001, Patient and Tumor Characteristics. SEER Program. NIH Pub. No. 07-6215. Bethesda, MD: National Cancer Institute. pp. 133–144.
- ↑ "The Internet Pathology Laboratory for Medical Education". The University of Utah Eccles Health Sciences Library. Retrieved 2009-06-27.
- ↑ Ovarian papillary serous cystadenocarcinoma at WebPath, The Internet Pathology Laboratory for Medical Education at Mercer University School of Medicine. Retrieved July 2011
This article is issued from Wikipedia - version of the 12/1/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.